Company news
Cannabis Bioscience International Holdings, Inc. news in 2025
Cannabis Bioscience International Holdings, Inc.'s news releases, calls and decks from 2025, newest first.
CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways
December 29, 2025
CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities
December 22, 2025
CBIH: Potential Rescheduling to Schedule III Could Reward Decades of Scientific Preparation and Regulatory Discipline
December 15, 2025
CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery
October 13, 2025
Cannabis Bioscience International Holdings, Inc. Appoints Veteran Financier Andy Trivedi to Its Board of Directors, Strengthening Capital Strategy and Growth Outlook
October 6, 2025
CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center
September 29, 2025
Presenting on the Emerging Growth Conference 78 Day 1 on January 15 Register Now
January 13, 2025
Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification
January 12, 2025
Cannabis Bioscience International Holdings (CBIH) Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products
January 5, 2025